Rapid Diagnosis of Germline p53 Mutation Using the Enzyme Mismatch Cleavage Method
- 1 December 1996
- journal article
- case report
- Published by Wolters Kluwer Health in Diagnostic Molecular Pathology
- Vol. 5 (4) , 265-270
- https://doi.org/10.1097/00019606-199612000-00007
Abstract
The p53 tumor suppressor gene is the most commonly altered gene in human cancers. Germline mutations in p53 are the genetic alteration underlying predisposition to multiple cancers in Li-Fraumeni syndrome and Li-Fraumeni-like syndrome. We describe a patient who presented with developed adrenocortical carcinoma at age 19 months and a cerebral primitive neuroectodermal tumor at age 5 years. The patient did not have a family history of cancer. We used the enzyme mismatch cleavage (EMC) method to screen for mutations in the p53 gene and found a germline mutation in exon 7 (codon 248). Loss of heterozygosity analysis in one tumor revealed loss of the wild-type p53 allele. In our report we demonstrate the EMC method to be a rapid and sensitive method for mutation detection.Keywords
This publication has 8 references indexed in Scilit:
- Screening for mutations by enzyme mismatch cleavage with T4 endonuclease VII.Proceedings of the National Academy of Sciences, 1995
- p53 and human cancersBritish Medical Bulletin, 1994
- A comparison of the biological activities of wild‐type and mutant p53The FASEB Journal, 1993
- Endonuclease VII of Phage T4 Triggers Mismatch Correction in VitroJournal of Molecular Biology, 1993
- Current methods of mutation detectionMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1993
- Germline mutations in the p53 tumour suppressor gene: scientific, clinical and ethical challengesBritish Journal of Cancer, 1992
- Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphismGenes, Chromosomes and Cancer, 1992
- Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other NeoplasmsScience, 1990